EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects

Federica Santino iD, Luca Gentilucci iD

Molecules · 01.01.2023 · 28 (1) · 346

DOI: 10.3390/molecules28010346 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 01.01.2023. Verfasst von Federica Santino und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry "G. Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy. Hauptthemen laut MEDLINE: Analgesia, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The κ-opioid receptor (KOR) has recently emerged as an alternative therapeutic target for the development of pain medications, without deleterious side effects associated with the μ-opioid receptor (MOR). However, modulation of KOR is currently under investigation for the treatment of depression, mood disorders, psychiatric comorbidity, and specific drug addictions. However, KOR agonists also trigger adverse effects including sedation, dysphoria, and hallucinations. In this respect, there is currently much debate on alternative paradigms. Recent effort has been devoted in search of biased ligands capable of selectively activating favorable signaling over signaling associated with unwanted side effects. On the other hand, the use of partial agonists is expected to allow the analgesia to be produced at dosages lower than those required to produce the adverse effects. More empirically, the unwanted central effects can be also avoided by using peripherally restricted agonists. In this review, we discuss the more recent trends in the design of KOR-selective, biased or partial, and finally, peripherally acting agonists. Special emphasis is given on the discussion of the most recent approaches for controlling functional selectivity of KOR-specific ligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnalgesiaDrug-Related Side Effects and Adverse ReactionsHumansLigandsPainReceptors, Opioid, kappaSignal TransductionAnalgesics, Opioid

Stichwörter der Autor:innen

antinociceptionbiased agonistdysphoriamolecular dockingmood disorderspartial agonistpeptidomimeticperipheral analgesiaκ-opioid receptor

Substanzen

LigandsReceptors, Opioid, kappaAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Chemistry "G. Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.

ORCID-Profile: Federica Santino, Luca Gentilucci

Zitieren

APA

Santino, F., & Gentilucci, L. (2023). Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects. Molecules, 28(1), 346. https://doi.org/10.3390/molecules28010346

Vancouver

Santino F, Gentilucci L. Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects. Molecules. 2023;28(1):346. doi:10.3390/molecules28010346

BibTeX
@article{Santino2023,
  author = {Santino, Federica and Gentilucci, Luca},
  title = {Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {1},
  pages = {346},
  doi = {10.3390/molecules28010346}
}
Kostenlos starten →